Orgenesis Inc Report


Orgenesis Inc. (ORGS) is a development stage company based in the USA, developing a novel method of treating diabetes using cell therapy to restore normal glucose-regulated insulin secretion. The technology is being researched and developed by the company’s Israeli arm Orgenesis Ltd. The new treatment methodology has seen encouraging results in pre-clinical studies both in-vivo and in-vitro, using mice and rodent models and human liver tissue. ORGS plans to advance to clinical trials as soon as it obtains the necessary funds.

To Download Full Report Kindly Login

A little more about Chris Engleman...

Comments are closed.